# E-Cigarette Aerosol, Conventional Cigarette Smoke, and Myocardial Perfusion

> **NCT02612701** · NA · TERMINATED · sponsor: **Cedars-Sinai Medical Center** · enrollment: 20 (estimated)

## Conditions studied

- Coronary Artery Disease
- Myocardial Perfusion

## Interventions

- **OTHER:** Cigarettes
- **OTHER:** E-cigarettes (nicotine free e-liquid)
- **OTHER:** E-cigarettes (low nicotine e-liquid)
- **OTHER:** E-cigarettes (high nicotine e-liquid)

## Key facts

- **NCT ID:** NCT02612701
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-10
- **Primary completion:** 2018-10-01
- **Final completion:** 2020-10
- **Target enrollment:** 20 (ESTIMATED)
- **Why stopped:** Due to the pandemic we decided to terminate this project.
- **Last updated:** 2021-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02612701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02612701, "E-Cigarette Aerosol, Conventional Cigarette Smoke, and Myocardial Perfusion". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02612701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*